This collaboration is managed by the NIHR Office for Clinical Research Infrastructure.
+44 (0)20 3794 7380
The NIHR Dementia Translational Research Collaboration (D-TRC) provides a network of world-leading investigators who are available to work with industry to further research and develop new treatments for dementia.
Our researchers are experts in translating new discoveries in dementia research from basic science into the clinic, and can provide access to patients from multiple sites across England.
The Dementia TRC is open to developing partnerships with companies to carry out experimental medicine investigations in:
These investigations focus on biomarker discovery and validation, early diagnosis, patient stratification, phase I and phase II experimental medicine and proof of concept trials.
For more information please visit the NIHR Dementia Translational Research Collaboration website.
The Dementia TRC undertakes commercial and non-commercial studies with industry partners. It is open to collaborations with any life sciences company, including pharmaceutical and diagnostic companies.
It will consider fully-funded projects as well as projects that will look for third party funding.
Read how the NIHR Dementia Translational Research Collaboration has collaborated with industry: